当前位置: X-MOL 学术Antimicrob. Agents Chemother. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction for Oh et al., “Development of a Broth Microdilution Method for Exebacase Susceptibility Testing”
Antimicrobial Agents and Chemotherapy ( IF 4.1 ) Pub Date : 2021-09-17 , DOI: 10.1128/aac.01658-21
Jun T Oh 1 , Jane E Ambler 1 , Cara Cassino 1 , Raymond Schuch 1
Affiliation  

Volume 65, no. 7, e02587-20, 2021, https://doi.org/10.1128/AAC.02587-20. In Table 4, a single methicillin-susceptible Staphylococcus aureus isolate inhibited by 0.12 μg/ml of exebacase is presented, and the remaining 148 isolates tested have an exebacase MIC range of 0.25 to 1 μg/ml. Further investigation of the isolate with an exebacase MIC of 0.12 μg/ml to confirm bacterial identification (by MALDI-TOF) and MIC revealed the isolate to be Staphylococcus pseudintermedius. Based on this finding, the authors wish to correct Table 4 and the corresponding text that refers to the S. aureus MIC data accordingly. With these corrections, the interpretation and conclusions of the article remain the same.

中文翻译:

Oh 等人的更正,“用于 Exebacase 敏感性测试的肉汤微量稀释方法的开发”

第 65 卷,没有。7、e02587-20,2021,https://doi.org/10.1128/AAC.02587-20。在表 4 中,呈现了一种被 0.12 μg/ml exebacase 抑制的对甲氧西林敏感的金黄色葡萄球菌分离株,其余 148 个测试的分离株的 exebacase MIC 范围为 0.25 至 1 μg/ml。进一步研究 exebacase MIC 为 0.12 μg/ml 的分离株以确认细菌鉴定(通过 MALDI-TOF)和 MIC 显示该分离株为假中间葡萄球菌。基于这一发现,作者希望相应地更正表 4 和引用金黄色葡萄球菌 MIC 数据的相应文本。通过这些更正,文章的解释和结论保持不变。
更新日期:2021-09-17
down
wechat
bug